In the last five months Amos de Jong (student Biomedical Sciences VU University Amsterdam) investigated the clinical trial monitoring process as part of his Master internship at Diagram. He specifically looked in what way sponsors and contract research organizations could improve protocol compliance through clinical trial monitoring.
Today the outcomes of his thesis, entitled ‘Towards Improved Clinical Trial Monitoring’, have been summarized and are available on our website.
The COVID-measures have heavily impacted many aspects of clinical research. We have experienced these issues as well at Diagram, so we are happy that many of our clinical research projects are currently re-starting.
The Coronavirus is continuing its spread around the world with all kind of measures as consequence. Recently it was decided in Europe to begin with easening the lock down measures. Based on the current measures the CCMO, IGJ and EMA have updated their COVID-19 guidelines.
Diagram is aware that there are challenges arising in relation to the Coronavirus (COVID-19) and the effect this is having on the conduct of clinical trials. Patients may be advised to stay away from hospitals due to existing health problems or they may be reluctant to travel.
Out of the box! Screening asymptomatic subjects at the Huishoudbeurs. For the DETECT AF project of dr. Arif Elvan we screen subjects of 65 year of age or older with a recently-developed smartphone connected Mobile ECG Device.